Francis Lo Adaptive Biotechnologies Corp (ADPT) insider trading activity

ADPT Quotes by TradingView

Francis Lo is Chief People Officer of Adaptive Biotechnologies Corp. Currently has a direct ownership of 253,745 shares of ADPT, which is worth approximately $1.35 Million. The most recent transaction as insider was on Mar 05, 2024, when has been sold 14,700 shares (Common Stock) at a price of $3.44 per share, resulting in proceeds of $50,568. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 254K
0% 3M change
50.62% 12M change
Total Value Held $1.35 Million

FRANCIS LO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 05 2024
SELL
Open market or private sale
$50,568 $3.44 p/Share
14,700 Reduced 5.48%
253,745 Common Stock
Mar 04 2024
BUY
Grant, award, or other acquisition
-
99,976 Added 27.14%
268,445 Common Stock
Mar 06 2023
SELL
Open market or private sale
$58,413 $8.57 p/Share
6,816 Reduced 3.89%
168,469 Common Stock
Mar 06 2023
BUY
Grant, award, or other acquisition
-
85,697 Added 32.84%
175,285 Common Stock
Mar 08 2022
SELL
Open market or private sale
$40,978 $11.44 p/Share
3,582 Reduced 3.84%
89,588 Common Stock
Mar 07 2022
SELL
Open market or private sale
$18,844 $12.01 p/Share
1,569 Reduced 1.66%
93,170 Common Stock
Mar 04 2022
BUY
Grant, award, or other acquisition
-
74,135 Added 43.9%
94,739 Common Stock
May 14 2021
SELL
Open market or private sale
$67,600 $33.8 p/Share
2,000 Reduced 8.85%
20,604 Common Stock
May 14 2021
BUY
Exercise of conversion of derivative security
$15,600 $7.8 p/Share
2,000 Added 8.13%
22,604 Common Stock
Apr 15 2021
SELL
Open market or private sale
$86,080 $43.04 p/Share
2,000 Reduced 8.85%
20,604 Common Stock
Apr 15 2021
BUY
Exercise of conversion of derivative security
$15,600 $7.8 p/Share
2,000 Added 8.13%
22,604 Common Stock
Mar 15 2021
SELL
Open market or private sale
$83,600 $41.8 p/Share
2,000 Reduced 8.85%
20,604 Common Stock
Mar 15 2021
BUY
Exercise of conversion of derivative security
$15,600 $7.8 p/Share
2,000 Added 8.13%
22,604 Common Stock
Mar 04 2021
BUY
Grant, award, or other acquisition
-
20,604 Added 50.0%
20,604 Common Stock
Feb 16 2021
SELL
Open market or private sale
$130,900 $65.45 p/Share
2,000 Reduced 100.0%
0 Common Stock
Feb 16 2021
BUY
Exercise of conversion of derivative security
$15,600 $7.8 p/Share
2,000 Added 50.0%
2,000 Common Stock
Jan 15 2021
SELL
Open market or private sale
$133,020 $66.51 p/Share
2,000 Reduced 100.0%
0 Common Stock
Jan 15 2021
BUY
Exercise of conversion of derivative security
$15,600 $7.8 p/Share
2,000 Added 50.0%
2,000 Common Stock
Dec 15 2020
SELL
Open market or private sale
$112,800 $56.4 p/Share
2,000 Reduced 100.0%
0 Common Stock
Dec 15 2020
BUY
Exercise of conversion of derivative security
$15,600 $7.8 p/Share
2,000 Added 50.0%
2,000 Common Stock
Nov 16 2020
SELL
Open market or private sale
$95,880 $47.94 p/Share
2,000 Reduced 100.0%
0 Common Stock
Nov 16 2020
BUY
Exercise of conversion of derivative security
$15,600 $7.8 p/Share
2,000 Added 50.0%
2,000 Common Stock
Oct 15 2020
SELL
Open market or private sale
$103,020 $51.51 p/Share
2,000 Reduced 100.0%
0 Common Stock
Oct 15 2020
BUY
Exercise of conversion of derivative security
$15,600 $7.8 p/Share
2,000 Added 50.0%
2,000 Common Stock
Oct 12 2020
SELL
Open market or private sale
$1,320,000 $52.8 p/Share
25,000 Reduced 100.0%
0 Common Stock
FL

Francis Lo

Chief People Officer
Seattle, WA

Track Institutional and Insider Activities on ADPT

Follow Adaptive Biotechnologies Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

News

Receive news related to Adaptive Biotechnologies Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADPT